Water content raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-10-21. Anything still debated is marked as such rather than presented as settled.
Mass spectrometry provides an identity check that complements chromatographic purity. Electrospray ionization or matrix-assisted laser desorption/ionization measures the mass-to-charge ratio of intact peptides. A match to the expected molecular mass supports correct sequence length and terminal groups. Mass accuracy alone does not prove that every peak in a liquid chromatogram is the target peptide. It also does not directly quantify how much water or counterion remains in a lyophilized powder.
Orthogonal methods reduce the chance that a single technique misses an impurity. Capillary electrophoresis separates by charge-to-size ratio and can resolve variants that co-elute under one set of HPLC conditions. Amino acid analysis reports composition after hydrolysis and confirms the presence of expected residues. Karl Fischer titration measures water content, while ion chromatography can quantify counterions. No single number captures all aspects of sample quality, so reports often combine several measurements.
Reverse-phase high-performance liquid chromatography is the most common primary method for peptide purity testing. The peptide mixture passes through a hydrophobic stationary phase, and components elute according to differences in hydrophobicity. A mobile phase of water and acetonitrile, often with trifluoroacetic acid as an ion-pairing agent, improves peak shape and retention. Ultraviolet detection at 214 nm records the peptide backbone absorbance, and the main peak area is divided by the total peak area to give an area-percent purity value.
Other chromatographic modes provide complementary information that reverse-phase separation may not capture. Ion-exchange chromatography separates peptides by net charge and can resolve deamidated, oxidized, or truncated variants that co-elute under hydrophobic conditions. Size-exclusion chromatography detects aggregates and higher-order oligomers, which are often invisible in reverse-phase assays. Chiral chromatography can quantify D-amino acid epimers when stereochemical purity matters. Because each mode uses a different separation principle, a single purity number from one method cannot describe all possible impurities.
| Property | Value | Notes |
|---|---|---|
| Primary purity method | Reverse-phase HPLC | Separates peptides by hydrophobicity; reports area percent. |
| Identity confirmation | Mass spectrometry | Electrospray or MALDI; matches observed mass to expected sequence. |
| Orthogonal separation | Capillary electrophoresis | Separates by charge-to-size ratio; complements HPLC. |
| Water content | Karl Fischer titration | Water dilutes peptide mass and affects concentration calculations. |
| Counterion | Trifluoroacetate or acetate | Common counterions alter net peptide content in lyophilized powder. |
Purity results are only meaningful when linked to a defined sample and method. A certificate of analysis typically lists the analytical technique, column type, gradient, detection wavelength, and integration parameters. It may also report mass confirmation, water content, and counterion composition. For research peptides, laboratories often request the raw chromatogram rather than only a summary percentage. This allows independent review of baseline, peak shape, and any unresolved shoulders that might be missed by a single number.
Stability testing examines how purity changes under controlled conditions. Samples are stored at defined temperatures, such as -20 °C or -80 °C, and analyzed at intervals. Lyophilized powders are generally more stable than solutions because water promotes hydrolysis and aggregation. Repeated freeze-thaw cycles can also degrade peptides, especially those with oxidation-prone residues. Accelerated studies at elevated temperature provide useful comparisons, but they do not always predict long-term behavior at lower temperatures.
Handling practices influence measured purity. Peptides may adsorb to plastic or glass surfaces, particularly when hydrophobic or positively charged. Weighing hygroscopic powders can introduce water and alter concentration. Dissolving in appropriate solvents and using low-binding tubes can reduce losses. Each laboratory should validate its own procedures because recovery and stability vary with peptide sequence, formulation, and container material. Open questions remain about how best to standardize stability reporting across different peptide classes.
Handling practices strongly affect measured purity and sample integrity. Many peptides are hygroscopic, susceptible to oxidation, or prone to adsorption on glass and plastic surfaces. Lyophilized powders are typically stored desiccated at -20 °C or below, while solutions may require colder storage and minimized freeze-thaw cycles. Peptides containing cysteine, methionine, or tryptophan can degrade through oxidation or disulfide exchange. Working aliquots reduce repeated exposure to moisture and temperature fluctuations during routine analysis.
Purity values do not necessarily predict biological potency. Net peptide content corrects for counterions such as acetate or trifluoroacetate, water, and residual salts. Impurity thresholds for reporting, identification, and qualification are often set according to regulatory guidance, though specific limits depend on the product class and route of administration. Open questions remain about the toxicological relevance of low-level peptide impurities and about how best to compare results across different analytical platforms. A certificate of analysis should state the methods used and the basis for each reported value.
Peptide purity testing distinguishes several impurity classes. Related substances include truncated sequences, deletion peptides, and diastereomers formed during synthesis, while residual solvents, counterions, and water are not peptide-related but affect mass balance. Aggregates and oxidation products can arise during storage. Each class requires different analytical approaches, and a complete purity profile combines separation, mass measurement, and orthogonal assays. Reporting only a single percentage can obscure which impurities are present, so the profile should name the methods and limits used.
Quality control relies on predefined specifications rather than a single purity number. A certificate of analysis typically lists the test method, acceptance limit, and measured result for each attribute. Common specifications include appearance, peptide content, water content, counterion identity, and related substances. Limits are set according to the peptide's intended use and the capability of the analytical method. A result outside a limit triggers investigation, not automatic rejection, because method variability and sample handling can affect outcomes.
Sample handling influences measured purity. Lyophilized peptides are hygroscopic and can absorb water, changing weight-based calculations, while repeated freeze-thaw cycles may promote aggregation or degradation. Dissolved samples should be prepared fresh when possible and protected from light and heat. In purity testing, the same handling conditions should apply to standards and samples. Stability-indicating methods are designed to separate degradation products from the parent peptide, though open questions remain about how accelerated stability data predict long-term behavior for every sequence.
== Life habits == This nudibranch feeds on hydroids and other marine organisms such as ascidians and sea anemones. It sometimes attacks other nudibranchs, and will eat smaller specimens of its own species. It is host to the ectoparasites Halicyclops thysanotus Wilson C.B., 1935 and Hemicyclops thysanotus Wilson C.B., 1935.
==== Arrest and death ==== In 1977, Biko broke his banning order by travelling to Cape Town, hoping to meet Unity Movement leader Neville Alexander and deal with growing dissent in the Western Cape branch of the BCM, which was dominated by Marxists like Johnny Issel. Biko drove to the city with his friend Peter Jones on 17 August, but Alexander refused to meet with Biko, fearing that he was being monitored by the police. Biko and Jones drove back toward King William's Town, but on 18 August they were stopped at a police roadblock near Grahamstown. Biko was arrested for having violated the order restricting him to King William's Town. Unsubstantiated claims have been made that the security services were aware of Biko's trip to Cape Town and that the road block had been erected to catch him. Jones was also arrested at the roadblock; he was subsequently held without trial for 533 days, during which time he was interrogated on numerous occasions. The security services took Biko to the Walmer police station in Port Elizabeth, where he was held naked in a cell with his legs in shackles. On 6 September, he was transferred from Walmer to room 619 of the security police headquarters in the Sanlam Building in central Port Elizabeth, where he was interrogated for 22 hours, handcuffed and in shackles, and chained to a grille. Exactly what happened has never been ascertained, but during the interrogation he was severely beaten by at least one of the ten security police officers. He suffered three brain lesions that resulted in a massive brain haemorrhage on 6 September.
2,4,5-Trimethoxyphenethylamine (2,4,5-TMPEA; 2C-O), the 2C positional isomer of mescaline (3,4,5-trimethoxyphenethylamine), was first synthesized by Max Jansen and was reported to produce psychedelic effects similar to those of mescaline in 1931. However, subsequent studies in the 1960s and 1970s suggested that 2,4,5-TMPEA may actually be inactive as a psychedelic in animals and humans. 2C-D was the first of the 2C drugs after 2C-O to be discovered. It was synthesized and studied in animals by Beng T. Ho and colleagues at the Texas Research Institute of Mental Sciences and they published their findings in 1970. Alexander Shulgin synthesized 2C-B and 2C-D in 1974 and discovered their psychedelic effects in self-experiments conducted in 1974 and 1975. He published his findings in the scientific literature in 1975. However, Shulgin had previously tested sub-threshold doses of 2C-D in 1964 and 1965. 2C-T was first described by Shulgin and David E. Nichols in 1976. 2C-I was first described by Shulgin and colleagues in 1977 and initial psychoactivity was reported by Shulgin in 1978. Shulgin also first synthesized 2C-E in 1977. He reviewed several of these 2C drugs in a literature review in 1979. Subsequently, numerous other 2C drugs have been synthesized and characterized. Shulgin comprehensively reviewed and described the 2C drugs in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved).
Sources: en.wikipedia.org
== Diagnosis == An appropriate diagnosis of hyperprolactinemia starts with conducting a complete clinical history before performing any treatment. Physiological causes, systemic disorders, and the use of certain drugs must be ruled out before the condition is diagnosed. Screening is indicated for those who are asymptomatic and those with elevated prolactin without an associated cause. The most common causes of hyperprolactinemia are prolactinomas, drug-induced hyperprolactinemia, and macroprolactinemia. Individuals with hyperprolactinemia may present with symptoms including galactorrhea, hypogonadism effects, and/or infertility. The magnitude that prolactin is elevated can be used as an indicator of the etiology of the hyperprolactinemia diagnosis. Prolactin levels over 250 ng/mL may suggest prolactinoma. Prolactin levels less than 100 ng/mL may suggest drug-induced hyperprolactinemia, macroprolactinemia, nonfunctioning pituitary adenomas, or systemic disorders. Prolactin levels over 500 ng/mL usually indicates the presence of macroprolactinoma, however, in patients with elevated serum prolactin ( >250 ng/mL) without evidence of prolactinoma, some medications such as metoclopramide, a dopamine receptor antagonist, can result in elevation of prolactin ( >200 ng/mL) in patients with no evidence of pituitary adenomas.
=== Ungrouped === CTDP1 CTDSP1, CTDSP2, CTDSPL DULLARD EPM2A ILKAP MDSP PGAM5 PHLPP1, PHLPP2 PPEF1, PPEF2 PPM1A, PPM1B, PPM1D, PPM1E, PPM1F, PPM1G, PPM1H, PPM1J, PPM1K, PPM1L, PPM1M, PPM1N PPTC7 PTPMT1 SSU72 UBLCP1
== Etymology == It is named for the English physician and anatomist Thomas Wharton (1614–1673) who first described it in his publication Adenographia, or "The Description of the Glands of the Entire Body", first published in 1656.
Sources: en.wikipedia.org
The sexism was evident in many ways, according to Mamphela Ramphele, a BCM activist and doctor at the Zanempilo Clinic, including that women tended to be given responsibility for the cleaning and catering at functions. "There was no way you could think of Steve making a cup of tea or whatever for himself", another activist said. Feminism was viewed as irrelevant "bra-burning". Surrounded by women who cared about him, Biko developed a reputation as a womaniser, something that Woods described as "well earned". He displayed no racial prejudice, sleeping with both black and white women. At NUSAS, he and his friends competed to see who could have sex with the most female delegates. Responding to this behaviour, the NUSAS general secretary Sheila Lapinsky accused Biko of sexism, to which he responded: "Don't worry about my sexism. What about your white racist friends in NUSAS?" Sobukwe also admonished Biko for his womanising, believing that it set a bad example to other activists. Biko married Ntsiki Mashalaba in December 1970. They had two children together: Nkosinathi, born in 1971, and Samora, born in 1975. Biko's wife chose the name Nkosinathi ("The Lord is with us"), and Biko named their second child after the Mozambican revolutionary leader Samora Machel. Angered by her husband's serial adultery, Mashalaba ultimately moved out of their home, and by the time of his death, she had begun divorce proceedings. Biko had also begun an extra-marital relationship with Mamphela Ramphele. In 1974, they had a daughter, Lerato, who died after two months.
The neuromedin U receptors are two G-protein coupled receptors which bind the neuropeptide hormones neuromedin U and neuromedin S. There are two subtypes of the neuromedin U receptor, each encoded by a separate gene (NMUR1, NMUR2).
== Taxonomy == The species was first described in 1906 as Stropharia cubensis by American mycologist Franklin Sumner Earle in Cuba. In 1907, it was identified as Naematoloma caerulescens in Tonkin (now Vietnam) by French pharmacist and mycologist Narcisse Théophile Patouillard, while in 1941, it was called Stropharia cyanescens by William Alphonso Murrill near Gainesville in Florida. German-born mycologist Rolf Singer moved the species into the genus Psilocybe in 1949, giving it the binomial name Psilocybe cubensis. The synonyms were later also assigned to the species Psilocybe cubensis. The name Psilocybe is derived from the Ancient Greek roots psilos (ψιλος) and kubê (κυβη), and translates as "bare head". Cubensis means "coming from Cuba", and refers to the type locality published by Earle. Singer divided P. cubensis into three varieties: the nominate, which usually had a brownish cap, Murrill's cyanescens from Florida, which generally had a pale cap, and var caerulascens from Indochina with a more yellowish cap. Psilocybe cubensis is commonly known as gold top, golden top or gold cap in Australia, sacred mushroom or blue mushroom in Brazil, and San Ysidro or Palenque mushroom in the United States and Mexico, while the term "magic mushroom" has been applied to hallucinogenic mushrooms in general. It is commonly known as "Golden teacher" in South Africa. A common name in Thai is "Hed keequai", which translates as "mushroom which appears after water buffalo defecates". Between 2013 and 2022, several samples of an unknown species of Psilocybe mushroom were collected.
=== Experience of treatment === Patients involved in treatment sometimes felt that treatment focused on biological aspects of body weight and eating behaviour change rather than their perceptions or emotional state. Patients felt that a therapist's trust in them shown by being treated as a complete person with their own capacities was significant. Some patients defined recovery from AN in terms of reclaiming a lost identity. Additionally, access to timely treatment can be hindered by systemic challenges within the medical system. Some individuals have reported experiencing delays in treatment, particularly when transitioning from adolescence to adulthood. Healthcare workers involved in the treatment of anorexia reported frustration and anger to setbacks in treatment and noncompliance and were afraid of patients dying. Some healthcare workers felt that they did not understand the treatment and that medical doctors were making decisions. They may feel powerless to improve a patient's situation and deskilled as a result. Healthcare workers involved in monitoring patients consumption of food felt watched themselves. Healthcare workers often feel a degree of moral dissonance of not being in control of outcomes which they may protect against by focusing on individual tasks, avoiding identifying with patients (for example by making their eating behavior very different and not sharing personal information with patients), and blaming patients for their distress. Healthcare workers would inflexibly follow process to avoid responsibility.
Sources: en.wikipedia.org
It measures the relative ultraviolet absorbance area of peptide peaks, usually at 214 nm. It does not directly measure mass, water, counterions, or co-eluting species.
HPLC and mass spectrometry answer different questions: HPLC estimates separation purity, while mass spectrometry confirms molecular mass. Orthogonal methods reduce the risk that one technique misses an impurity.
Yes. Area percent excludes water, counterions, residual solvents, and any species that co-elute with the target peak. Net peptide content can therefore be lower than the reported HPLC purity.
HPLC purity measures the relative area of the main peptide peak compared with all detected peaks under one set of separation and detection conditions. It is an operational value rather than an absolute mass fraction. Compounds that do not absorb at the detection wavelength or that co-elute with the main peak are not counted.